Phenotypic Implications of CYP2C19*4 and*4B Detection in the General Population

被引：0
|
作者：
Borgman, M. P. [1 ]
Reynolds, K. K. [1 ]
Valdes, R. [1 ]
Linder, M. W. [1 ]
机构：
[1] PGXL Labs, Louisville, KY USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：857 / 857
页数：1
相关论文
共 50 条
  • [41] CYP2C19 and CYP3A4 gene variants and schizophrenia in Armenian patients
    Butenko, E. V.
    Mamedov, R. F. O.
    Ghazaryan, H. K.
    Zakharyan, R. V.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 269 - 270
  • [42] Metabolism of tilidine by human liver microsomes, CYP3A4 and CYP2C19
    Sawa, E.
    Riedel, K. D.
    Haefeli, W. E.
    Mikus, G.
    Weiss, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 377 - 377
  • [43] Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped
    Gautier-Veyret, E.
    Fonrose, X.
    Stanke-Labesque, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 189 - 189
  • [44] INFLUENCE OF CYP2C19 AND CYP3A4 ON TILIDINE PHARMACOKINETICS AND METABOLISM IN HUMANS
    Merkel, U.
    Riedel, K. -D.
    Gruen, B.
    Mikus, G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 : 22 - 22
  • [45] Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population
    Larsen, P. D.
    Johnston, L. R.
    Holley, A.
    La Flamme, A. C.
    Smyth, L.
    Chua, E. W.
    Kennedy, M. A.
    Harding, S. A.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (05) : 537 - 545
  • [46] CYP3A4 and CYP2C19 genetic polymorphisms and zolpidem metabolism in the Chinese Han population: A pilot study
    Shen, Min
    Shi, Yan
    Xiang, Ping
    FORENSIC SCIENCE INTERNATIONAL, 2013, 227 (1-3) : 77 - 81
  • [47] Imipramine demethylation in vivo: Impact of CYP1A2, CYP2C19, and CYP3A4
    Madsen, H
    Rasmussen, BB
    Brosen, K
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (03) : 319 - 324
  • [48] EVIDENCE THAT CYP2C19 IS THE MAJOR (S)-MEPHENYTOIN 4'-HYDROXYLASE IN HUMANS
    GOLDSTEIN, JA
    FALETTO, MB
    ROMKESSPARKS, M
    SULLIVAN, T
    KITAREEWAN, S
    RAUCY, JL
    LASKER, JM
    GHANAYEM, BI
    BIOCHEMISTRY, 1994, 33 (07) : 1743 - 1752
  • [49] Allele and genotype frequency of CYP2C19 in a Tamilian population
    Adithan, C
    Gerard, N
    Vasu, S
    Rosemary, J
    Shashindran, CH
    Krishnamoorthy, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (03) : 331 - 333
  • [50] Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population
    Gulati, Sachin
    Yadav, Anita
    Kumar, Neeraj
    Kanupriya
    Kumar, Gaurav
    Aggarwal, Neeraj
    Gupta, Ranjan
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2014, 37 (03) : 1186 - 1193
12345